DRIEHAUS CAPITAL MANAGEMENT LLC - REPROS THERAPEUTICS INC ownership

REPROS THERAPEUTICS INC's ticker is RPRX and the CUSIP is 76028H209. A total of 78 filers reported holding REPROS THERAPEUTICS INC in Q3 2014. The put-call ratio across all filers is 0.57 and the average weighting 0.1%.

Quarter-by-quarter ownership
DRIEHAUS CAPITAL MANAGEMENT LLC ownership history of REPROS THERAPEUTICS INC
ValueSharesWeighting
Q2 2014$1,281,000
-5.5%
74,035
-3.1%
0.04%
-2.3%
Q1 2014$1,355,000
+6.9%
76,388
+10.4%
0.04%
-6.5%
Q4 2013$1,267,000
-79.6%
69,221
-70.1%
0.05%
-80.8%
Q3 2013$6,201,000
-31.6%
231,433
-52.9%
0.24%
-39.6%
Q2 2013$9,065,000491,3500.40%
Other shareholders
REPROS THERAPEUTICS INC shareholders Q3 2014
NameSharesValueWeighting ↓
SPHERA FUNDS MANAGEMENT LTD. 978,800$1,292,0000.33%
Allegis Investment Advisors, LLC 344,487$455,0000.14%
GENERAL AMERICAN INVESTORS CO INC 589,768$778,0000.08%
Acrospire Investment Management LLC 23,177$31,0000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 268,130$354,0000.01%
Alambic Investment Management, L.P. 16,091$21,0000.00%
OXFORD ASSET MANAGEMENT LLP 51,359$68,0000.00%
Renaissance Technologies 716,413$946,0000.00%
BENJAMIN F. EDWARDS & COMPANY, INC. 2,700$4,0000.00%
Virtu KCG Holdings LLC 45,144$60,0000.00%
View complete list of REPROS THERAPEUTICS INC shareholders